Profile: Oxford Biosignals Limited provides clinical solutions for safer hospitals, safer patients and safer drugs. Our Visensia® simplifies early detection of patient deterioration while optimizing the quality of care and resource utilization. It automatically analyzes and interprets the combined patterns of a patient's four or five vital signs, regardless of whether they are collected continuously or periodically. These data are fused to generate a predictive, numerical index (Visensia index) representing the patient's wellness throughout the hospital stay. Our BioQT® provides comprehensive ECG analysis for pharmaceutical cardiac safety, through QT interval measurement and T-wave morphology. It separates beats from noisy beats by assigning confidence level for each machine-processed result.

FDA Registration Number: 3000162901
US Agent: Ron Eisenwinter / Obs Medical Ltd
Phone: +1-(617)-964-2962  Fax: +1-(617)-964-2962  E-Mail: